Imatinib-induced immune hepatitis: Case report and literature review

Hematology

Volumn 12, Issue 1, 2007, Pages 49-53

  Al Sobhi, Enaam ^a   Zahrani, Zayed ^a   Zevallos, Eduardo ^a   Zuraiki, Abdo ^a  

^a KING KHALID NATIONAL GUARD HOSPITAL   (Saudi Arabia)

Author keywords

Gleevec; Hepatotoxicity; Imatinib; Immune hepatitis

Indexed keywords

AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; HYDROXYUREA; IMATINIB; IMMUNOGLOBULIN G; PREDNISOLONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SMOOTH MUSCLE ANTIBODY;

ADOLESCENT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BONE MARROW BIOPSY; CASE REPORT; CHRONIC HEPATITIS; CHRONIC MYELOID LEUKEMIA; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTOGENETICS; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG WITHDRAWAL; ECHOGRAPHY; FEMALE; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HUMAN; INTERNATIONAL NORMALIZED RATIO; JAUNDICE; LEUKEMIA REMISSION; LEUKOCYTE COUNT; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER TOXICITY; PHILADELPHIA CHROMOSOME NEGATIVE CELL; PHILADELPHIA CHROMOSOME POSITIVE CELL; PRIORITY JOURNAL; SPLENOMEGALY; THROMBOCYTE COUNT; TOXIC HEPATITIS;

ADOLESCENT; ALANINE TRANSAMINASE; ANTIBODIES, ANTINUCLEAR; ANTIBODY SPECIFICITY; ANTINEOPLASTIC AGENTS; ASPARTATE AMINOTRANSFERASES; AUTOANTIBODIES; AUTOANTIGENS; DNA; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JAUNDICE, OBSTRUCTIVE; LEUKEMIA, MYELOID, CHRONIC-PHASE; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MUSCLE, SMOOTH; PIPERAZINES; PREDNISOLONE; PYRIMIDINES;

EID: 33947164748     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330600937929     Document Type: Article

References (11)

1. Schwetz, B. (2001) New treatment for chronic myeloid leukemia. JAMA, 286:1, p. 35.
2. Walid, S., Ayoub, WS, Geller, SA, Tran, T., Martin, P., Vierling, JM and Poordad, FF (2005) Imatinib (Gleevec)-induced hepatotoxicity. J Clin Gastroentero, 39:1, pp. 75-77.
3. Cohen, MH, Williams, G., Johnson, JR, Duan, J., Gobburu, J., Rahman, A., Benson, K., Leighton, J., Kim, SK, Wood, R., Rothmann, M., Chen, G., Staten, AM and Pazdur, R. (2002) Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia. Clin Cancer Res, 8:5, pp. 934-935.
4. Deininger, Michael WN, O'Brien, Stephen G., Ford, John M. and Druker, Brian J. (2003) Practical management of patients with chronic myeloid leukemia receiving imatinib. J Clin Oncol, p. 21.
5. James, C., Trouette, H., Marit, G., Cony-Makhoul, P. and Mahon, FX (2003) Histological features of acute hepatitis after imatinib mesylate treatment. Leukemia, 17:5, pp. 978-979.
6. Kikuchi, S., Muroi, K., Takahashi, S., Kawano-Yamamoto, C., Takatoku, M., Miyazato, A., Nagai, T., Mori, M., Komatsu, N. and Ozawa, K. (2004) Severe hepatitis and complete molecular response caused by imatinib mesylate: Possible association of its serum concentration with clinical outcomes. Leuk Lymphoma, 45:11, pp. 2349-2351.
7. Ohyashiki, K., Kuriyama, Y., Nakajima, A., Tauchi, T., Ito, Y., Miyazawa, H., Kimura, Y., Serizawa, H. and Ebihara, Y. (2002) Imatinib mesylate-induced hepato-toxicity in chronic myeloid leukemia demonstrated focal necrosis resembling acute viral hepatitis. Leukemia, 16:10, pp. 2160-2161.
8. Ikeda, K., Shiga, Y., Takahashi, A., Kai, T., Kimura, H., Takeyama, K., Noji, H., Ogawa, K., Nakamura, A., Ohira, H., Sato, Y. and Maruyama, Y. (2006) Fatal hepatitis B virus reactivation in a chronic myeloid leukemia patient during imatinib mesylate treatment. Leuk Lymphoma, 47:1, pp. 155-157.
9. Batt, AM and Ferrari, L. (1995) Manifestations of chemically induced liver damage. Clin Chem, 41:12, pp. 1882-1887.
10. Rocca, P., Jastimi, S El, Troncy, J., Scoazec, JY, Boucher, A., Vial, T., Trepo, C. and Zoulim, F. (2004) Imatinib mesylate-induced acute cytolytic hepatitis. Gastroenterol Clin Biol, 28:10, pp. 918-919.
11. Parise, RA, Ramanathan, RK, Hayes, MJ and Egorin, MJ (2003) Liquid chromatographic-mass spectrometric assay for quantitation of imatinib and its main metabolite (CGP 74588) in plasma. J Chromatogr B Analyt Technol Biomed Life Sci, 791:12, pp. 39-44.